Found: 6
Select item for more details and to access through your institution.
Effectiveness of first-line anticancer treatment may predict treatment response in further lines in stage III/IV patients with non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 19, p. 17123, doi. 10.1007/s00432-023-05431-5
- By:
- Publication type:
- Article
Non-small Cell Lung Cancer as a Chronic Disease -- A Prospective Study from the Czech TULUNG Registry.
- Published in:
- In Vivo, 2020, v. 34, n. 1, p. 369, doi. 10.21873/invivo.11783
- By:
- Publication type:
- Article
Oral Vinorelbine Plus Cisplatin as First-Line Chemotherapy in Nonsquamous Non-Small-Cell Lung Cancer: Final Results of an International Randomized Phase II Study (NAVotrial 01)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Oral Vinorelbine Plus Cisplatin as First-Line Chemotherapy in Nonsquamous Non--Small-Cell Lung Cancer: Final Results of an International Randomized Phase II Study (NAVotrial 01).
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 4, p. 258, doi. 10.1016/j.cllc.2014.04.007
- By:
- Publication type:
- Article
An ocular lesion of unknown aetiology.
- Published in:
- Breathe, 2021, v. 17, n. 2, p. 1, doi. 10.1183/20734735.0164-2020
- By:
- Publication type:
- Article
Real‐life effectiveness of first‐line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 11, p. 3346, doi. 10.1111/1759-7714.13679
- By:
- Publication type:
- Article